Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Slides:

Advertisements

Similar presentations

Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood.

Advertisements

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.

Severity of Coronary Arterial Stenoses Responsible for Acute Coronary Syndromes Ganesh Manoharan, MD, Argyrios Ntalianis, MD, Olivier Muller, MD, PhD,

PP-183 [AJC » Percutaneous coronary interventions in acute coronary syndromes] Succesful Treatment and Management of LMCA Acute Total Occlusion in a Patient.

The Epidemic of the 20th Century: Coronary Heart Disease

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the.

Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.

The “occasional open heart surgeon” revisited

Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and.

Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Community-Based Mind–Body Meditative Tai Chi Program and Its Effects on Improvement of Blood Pressure, Weight, Renal Function, Serum Lipoprotein, and.

Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.

Meta-Analysis of Dietary Glycemic Load and Glycemic Index in Relation to Risk of Coronary Heart Disease Jia-Yi Dong, BSc, Yong-Hong Zhang, MD, PhD, Peiyu.

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the.

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Catheter-Based Treatment of Coronary Artery Disease

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Standardizing definitions for hybrid coronary revascularization

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease Glenn N. Levine, MD, FACC, FAHA,

The Epidemic of the 20th Century: Coronary Heart Disease

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Gout in African Americans

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.

Multilevel data analysis: What? Why? How?

Risk Stratification and Interventional Cardiology: Robert L

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Extracorporeal Membrane Oxygenation for Advanced Refractory Shock in Acute and Chronic Cardiomyopathy Christian A. Bermudez, MD, Rodolfo V. Rocha, MD,

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Presentation transcript:

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) Samip Vasaiwala, MD, MSc, Helen Vlachos, MSc, Faith Selzer, PhD, Oscar Marroquin, MD, Suresh Mulukutla, MD, J. Dawn Abbott, MD, David O. Williams, MD American Journal of Cardiology Volume 110, Issue 8, Pages 1113-1118 (October 2012) DOI: 10.1016/j.amjcard.2012.05.051 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 Kaplan–Meier plots of 3-year cumulative incidence of (A) death, (B) myocardial infarction, and (C) coronary artery bypass grafting/repeat percutaneous coronary intervention in patients undergoing percutaneous coronary intervention for ostial lesions using bare-metal versus drug-eluting stents. American Journal of Cardiology 2012 110, 1113-1118DOI: (10.1016/j.amjcard.2012.05.051) Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 2 Adjusted hazard rates/relative risk of patients undergoing percutaneous coronary intervention for ostial lesions. AHR = adjusted hazard ratio; CABG = coronary artery bypass grafting. American Journal of Cardiology 2012 110, 1113-1118DOI: (10.1016/j.amjcard.2012.05.051) Copyright © 2012 Elsevier Inc. Terms and Conditions